UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Etiology of hearing loss in adults

Author
Peter C Weber, MD, FACS
Section Editor
Daniel G Deschler, MD, FACS
Deputy Editor
H Nancy Sokol, MD

INTRODUCTION

Hearing loss is a common problem that everyone experiences from time to time. Most commonly it occurs when flying or traveling up a mountain, and a full sensation develops in the ears, leading to the feeling of wanting to pop the ears open in order to hear better. Diminished hearing may also occur during an ear infection. These causes of hearing loss are usually short-lived. The other extreme is the permanent sensorineural hearing loss that occurs with aging, which we will all experience to some degree. The causes of hearing loss are reviewed here, along with brief discussions of the management of certain conditions.

The evaluation of a patient with hearing loss and hearing loss in children are discussed separately. (See "Evaluation of hearing loss in adults" and "Hearing impairment in children: Etiology" and "Hearing impairment in children: Evaluation" and "Hearing impairment in children: Treatment".)

EPIDEMIOLOGY

Hearing loss is a common chronic impairment, particularly for older adults. In the Beaver Dam cohort in the United States, the prevalence of hearing loss, defined by audiometry, increased steadily with age [1]:

3 percent ages 21 to 34

6 percent ages 35 to 44

                                       

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Fri Nov 04 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Nash SD, Cruickshanks KJ, Klein R, et al. The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study. Arch Otolaryngol Head Neck Surg 2011; 137:432.
  2. Stevens G, Flaxman S, Brunskill E, et al. Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Public Health 2013; 23:146.
  3. Teufert KB, De la Cruz A. Advances in congenital aural atresia surgery: effects on outcome. Otolaryngol Head Neck Surg 2004; 131:263.
  4. Declau F, Cremers C, Van de Heyning P. Diagnosis and management strategies in congenital atresia of the external auditory canal. Study Group on Otological Malformations and Hearing Impairment. Br J Audiol 1999; 33:313.
  5. Yellon RF. Congenital external auditory canal stenosis and partial atretic plate. Int J Pediatr Otorhinolaryngol 2009; 73:1545.
  6. Fuchsmann C, Tringali S, Disant F, et al. Hearing rehabilitation in congenital aural atresia using the bone-anchored hearing aid: audiological and satisfaction results. Acta Otolaryngol 2010; 130:1343.
  7. Vrabec JT, Lin JW. Inner ear anomalies in congenital aural atresia. Otol Neurotol 2010; 31:1421.
  8. Kinney SE. Malignancies of the temporal bone-limited bone resection. In: Otologic Surgery, Brackman DE (Ed), WB Saunders, Philadelphia 1994. p.38.
  9. Nyrop M, Grøntved A. Cancer of the external auditory canal. Arch Otolaryngol Head Neck Surg 2002; 128:834.
  10. Gidley PW, Roberts DB, Sturgis EM. Squamous cell carcinoma of the temporal bone. Laryngoscope 2010; 120:1144.
  11. DiBartolomeo JR. Exostoses of the external auditory canal. Ann Otol Rhinol Laryngol Suppl 1979; 88:2.
  12. Kroon DF, Lawson ML, Derkay CS, et al. Surfer's ear: external auditory exostoses are more prevalent in cold water surfers. Otolaryngol Head Neck Surg 2002; 126:499.
  13. House JW, Wilkinson EP. External auditory exostoses: evaluation and treatment. Otolaryngol Head Neck Surg 2008; 138:672.
  14. Hsiao SH, Liu TC. Osteoma of the external ear canal. Otol Neurotol 2003; 24:960.
  15. Tan TY, Goh JP. Imaging of congenital middle ear deafness. Ann Acad Med Singapore 2003; 32:495.
  16. Chole RA. Acute and chronic infections of the temporal bone including otitis media with effusion. In: Otolaryngology: Head & Neck Surgery, Cummings CW (Ed), CV Mosby Co, St. Louis 1986. p.2963.
  17. Klein JO. Microbiology of otitis media. Ann Otol Rhinol Laryngol Suppl 1980; 89:98.
  18. Ryding M, Konradsson K, White P, Kalm O. Hearing loss after "refractory" secretory otitis media. Acta Otolaryngol 2005; 125:250.
  19. Lyon JL, Ashton A, Turner B, Magill M. Variation in the diagnosis of upper respiratory tract infections and otitis media in an urgent medical care practice. Arch Fam Med 1998; 7:249.
  20. Lesinskas E. Factors affecting the results of nonsurgical treatment of secretory otitis media in adults. Auris Nasus Larynx 2003; 30:7.
  21. Symposium on pediatric otolaryngology. Pediatr Clin North Am 1981; 28:727.
  22. Bluestone CD, Klein JO. Intratemporal complications and sequelae of otitis media. In: Pediatric Otolaryngology, Bluestone CD, Stool SE (Eds), WB Saunders, 1983. Vol I.
  23. Hellström S, Groth A, Jörgensen F, et al. Ventilation tube treatment: a systematic review of the literature. Otolaryngol Head Neck Surg 2011; 145:383.
  24. Sudhoff H, Tos M. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory. Am J Otol 2000; 21:786.
  25. Abdurehim Y, Lehmann A, Zeitouni AG. Stapedotomy vs Cochlear Implantation for Advanced Otosclerosis: Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2016; 155:764.
  26. Causse JR, Causse JB, Uriel J, et al. Sodium fluoride therapy. Am J Otol 1993; 14:482.
  27. Bretlau P, Salomon G, Johnsen NJ. Otospongiosis and sodium fluoride. A clinical double-blind, placebo-controlled study on sodium fluoride treatment in otospongiosis. Am J Otol 1989; 10:20.
  28. Derks W, De Groot JA, Raymakers JA, Veldman JE. Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation. Acta Otolaryngol 2001; 121:174.
  29. Saliba I, Abela A, Arcand P. Tympanic membrane perforation: size, site and hearing evaluation. Int J Pediatr Otorhinolaryngol 2011; 75:527.
  30. Lee DH. Re: A randomised controlled trial comparing spontaneous healing, gelfoam patching, and edge-approximation plus gelfoam patching in traumatic tympanic membrane perforation with in-/everted edges. Clin Otolaryngol 2011; 36:399.
  31. Lou ZC, Hu YX, Tang YM. Effect of treatment at different time intervals for traumatic tympanic membrane perforation on the closure. Acta Otolaryngol 2011; 131:1032.
  32. Farmer, JC Jr. Eustachian tube function and otologic barotrauma. Ann Otol Rhinol Laryngol 1985; 120 suppl:45.
  33. Michaund, M, Escobar, S, Parker, G. Diving injuries and the otolaryngologist. Current Opinion in Otolaryngology and Head and Neck Surgery1999; 7:155.
  34. Melamed Y, Shupak A, Bitterman H. Medical problems associated with underwater diving. N Engl J Med 1992; 326:30.
  35. ALFORD BR, GUILFORD FR. A comprehensive study of tumors of the glomus jugulare. Laryngoscope 1962; 72:765.
  36. House JW, Fayad JN. Glomus tympanicum. Ear Nose Throat J 2005; 84:548.
  37. Poznanovic SA, Cass SP, Kavanagh BD. Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors. Otolaryngol Head Neck Surg 2006; 134:437.
  38. Gottfried ON, Liu JK, Couldwell WT. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004; 17:E4.
  39. Grundfast KM. Hearing loss. In: Pediatric Otolaryngology, Bluestone CD, Stool SE (Eds), WB Saunders, Philadelphia 1990. p.203.
  40. Ruben RR. Diseases of the inner ear and sensorineural deafness. In: Pediatric Otolaryngology, Bluestone CD, Stool SE (Eds), WB Saunders, Philadelphia 1990. p.547.
  41. Petersen MB, Willems PJ. Non-syndromic, autosomal-recessive deafness. Clin Genet 2006; 69:371.
  42. Schultz JM, Yang Y, Caride AJ, et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N Engl J Med 2005; 352:1557.
  43. Angeli SI. Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. Laryngoscope 2008; 118:2014.
  44. Schimmenti LA, Martinez A, Telatar M, et al. Infant hearing loss and connexin testing in a diverse population. Genet Med 2008; 10:517.
  45. Weber PC, Perez BA, Bluestone CD. Congenital perilymphatic fistula and associated middle ear abnormalities. Laryngoscope 1993; 103:160.
  46. Weber PC, Bluestone CD, Kenna MA, Kelley RH. Correlation of beta-2 transferrin and middle ear abnormalities in congenital perilymphatic fistula. Am J Otol 1995; 16:277.
  47. Lin FR. Hearing loss and cognition among older adults in the United States. J Gerontol A Biol Sci Med Sci 2011; 66:1131.
  48. Weber PC, Zbar RI, Gantz BJ. Appropriateness of magnetic resonance imaging in sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 1997; 116:153.
  49. Barr, G, Widenberg, E. Prognosis of perceptive hearing loss in children with respect to genesis and use of hearing aid. Acta Otolaryngol 1965; 59:462.
  50. Gifford RH, Dorman MF, Shallop JK, Sydlowski SA. Evidence for the expansion of adult cochlear implant candidacy. Ear Hear 2010; 31:186.
  51. Heman-Ackah SE, Roland JT Jr, Haynes DS, Waltzman SB. Pediatric cochlear implantation: candidacy evaluation, medical and surgical considerations, and expanding criteria. Otolaryngol Clin North Am 2012; 45:41.
  52. Eisenman D, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000; 126:1161.
  53. Hashisaki GT. Which treatment for sudden sensorineural hearing Loss? Arch Otolaryngol Head Neck Surg 2000; 126:1165.
  54. Weber PC, Adkins WY Jr. The differential diagnosis of Meniere's disease. Otolaryngol Clin North Am 1997; 30:977.
  55. Minor LB, Schessel DA, Carey JP. Ménière's disease. Curr Opin Neurol 2004; 17:9.
  56. Prasher D. New strategies for prevention and treatment of noise-induced hearing loss. Lancet 1998; 352:1240.
  57. Balatsouras DG, Tsimpiris N, Korres S, et al. The effect of impulse noise on distortion product otoacoustic emissions. Int J Audiol 2005; 44:540.
  58. Recommendations for a noise standard. In: Occupational Noise Exposure: NIOSH Publication Number 98-126/CDC/NIOSH. www.cdc.gov/niosh/docs/98-126/chap1.html (Accessed on December 19, 2006).
  59. Moon RE. Treatment of diving emergencies. Crit Care Clin 1999; 15:429.
  60. Parell GJ, Becker GD. Conservative management of inner ear barotrauma resulting from scuba diving. Otolaryngol Head Neck Surg 1985; 93:393.
  61. Ishman SL, Friedland DR. Temporal bone fractures: traditional classification and clinical relevance. Laryngoscope 2004; 114:1734.
  62. Cannon CR, Jahrsdoerfer RA. Temporal bone fractures. Review of 90 cases. Arch Otolaryngol 1983; 109:285.
  63. Jackler RK. Acoustic neuroma. In: Neurotology, Jackler R, Brackman DE (Eds), CV Mosby, St. Louis 1994. p.729.
  64. Bainbridge KE, Hoffman HJ, Cowie CC. Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med 2008; 149:1.
  65. Houston DK, Johnson MA, Nozza RJ, et al. Age-related hearing loss, vitamin B-12, and folate in elderly women. Am J Clin Nutr 1999; 69:564.
  66. Berner B, Odum L, Parving A. Age-related hearing impairment and B vitamin status. Acta Otolaryngol 2000; 120:633.
  67. Durga J, Verhoef P, Anteunis LJ, et al. Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial. Ann Intern Med 2007; 146:1.
  68. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88:585.
  69. Ruckenstein MJ. Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 2004; 12:426.
  70. Harris JP, Weisman MH, Derebery JM, et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 2003; 290:1875.
  71. Alexander TH, Weisman MH, Derebery JM, et al. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol 2009; 30:443.
  72. Jackson CA. Autoimmune inner ear disease. In: Neurotology, Jackler R, Brackman DE (Eds), CV Mosby, St. Louis 1994. p.516.
  73. Salley LH Jr, Grimm M, Sismanis A, et al. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients. J Rheumatol 2001; 28:1037.
  74. Roland PS, Stewart MG, Hannley M, et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: Introduction, methodology, and recommendations. Otolaryngol Head Neck Surg 2004; 130:S51.
  75. Curhan SG, Eavey R, Shargorodsky J, Curhan GC. Analgesic use and the risk of hearing loss in men. Am J Med 2010; 123:231.
  76. Curhan SG, Shargorodsky J, Eavey R, Curhan GC. Analgesic use and the risk of hearing loss in women. Am J Epidemiol 2012; 176:544.
  77. Maddox PT, Saunders J, Chandrasekhar SS. Sudden hearing loss from PDE-5 inhibitors: A possible cellular stress etiology. Laryngoscope 2009; 119:1586.
  78. McGwin G Jr. Phosphodiesterase type 5 inhibitor use and hearing impairment. Arch Otolaryngol Head Neck Surg 2010; 136:488.
  79. Khan AS, Sheikh Z, Khan S, et al. Viagra deafness--sensorineural hearing loss and phosphodiesterase-5 inhibitors. Laryngoscope 2011; 121:1049.
  80. Stenner M, Stürmer K, Beutner D, Klussmann JP. Sudden bilateral sensorineural hearing loss after intravenous cocaine injection: a case report and review of the literature. Laryngoscope 2009; 119:2441.
  81. Prasher D. Heavy metals and noise exposure: health effects. Noise Health 2009; 11:141.
  82. Weber PC, Cass SP. Clinical assessment of postural stability. Am J Otol 1993; 14:566.
  83. Fischer C, Mauguière F, Ibanez V, et al. The acute deafness of definite multiple sclerosis: BAEP patterns. Electroencephalogr Clin Neurophysiol 1985; 61:7.